Resumen

CHACON JIMENEZ, Nancy Katalina; JIMENEZ BERMUDEZ, Juan Pablo  y  CARBALLO SOLIS, Katiana Dialá. Antibiotic therapy in community acquired pneumonia. Rev. costarric. salud pública [online]. 2019, vol.28, n.2, pp.141-154. ISSN 1409-1429.

Pneumonia is an infection located in lung parenchyma that can be classified according to the place of acquisition into Community-Acquired Pneumonia (CAP) or Hospital and Healthcare-Acquired Pneumonia, which is of major importance to define the physician management. In this article the main idea to present the bacterial CAP giving special importance to those caused by Sreptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae y Legionella sp.

In addition, the following article approaches the clinical presentation and diverse laboratory tests to complement an accurate diagnosis and the evolution of the disease. The scores PSI, CURB65, SMART-COP and SCAP can be a very useful tool to help the physician determine if the patient needs to be hospitalized in an internal medicine service, intensive care unit or if the case can be handled as an outpatient.

The antibiotics are keystone to treat the pneumonia, and different therapies designed to manage CAP in outpatients and inpatients are explained, such as amoxicillin, amoxixillin/clavulanate, azithromycin, cefdinir, moxifloxacin among others; as well as the criteria to determine the optimal duration of the treatment. As an addition the recommendations given by the National Institute for Health and Care Excellence (NICE) are provided to the physicians as a tool to improve patient’s education and optimize the initial approach and management.

Palabras clave : pneumonia; antibiotic; Mycoplasma pneumoniae; Streptococcus pneumoniae.

        · resumen en Español     · texto en Español     · Español ( pdf )